Stem Cell Preservation
Cord blood banking involves collecting blood left in your newborn's umbilical cord and placenta and storing it for future medical use. Cord blood contains potentially lifesaving cells called stem cells. (The stem cells in cord blood are different from embryonic stem cells.) Stem cells are the building blocks of the blood and immune system. They have the ability to develop into other types of cells, so they can help repair tissues, organs, and blood vessels and can be used to treat a host of diseases.
Cord blood banking involves collecting blood left in your newborn's umbilical cord and placenta and storing it for future medical use. Cord blood contains potentially lifesaving cells called stem cells. (The stem cells in cord blood are different from embryonic stem cells.) Stem cells are the building blocks of the blood and immune system. They have the ability to develop into other types of cells, so they can help repair tissues, organs, and blood vessels and can be used to treat a host of diseases.
Cord blood stem cells have been used successfully to treat more than 70 different diseases, including some cancers, blood disorders, and immune deficiencies. Among these are leukemia, aplastic anemia, thalassemia, Hodgkin's disease, and non-Hodgkin's lymphoma. Cord blood transplants are also used to treat rare metabolic disorders that would otherwise be fatal for infants (Krabbe disease and Sanfilippo syndrome).
Cocoon has associated with Cryoviva Biotech for stem cells banking , which is founded by RJ Corp in 2006. The company is focused on providing high-quality umbilical cord blood stem cell processing, and storage for both private and public donation purposes. Based at Gurgaon with networks in all the towns of India provides a high end processing and storage technology which are approved by International authorities. Cryoviva India has spread beyond the shores to Thailand, UAE, Nepal, Bangladesh and East Africa making it the only Indian Cord Blood bank available in International Market. Cryoviva India has set up 28,000 square feet, state-of-the-art stem cell processing and banking facility in Gurgaon Haryana. The company is working towards national and international collaborations to provide the “best of class” facilities in stem cell industry in India. Cryoviva India follows the “Closed bag” collection method for harvesting cord blood stem cells which greatly reduces the possibility of contamination of cord blood and uses technology accredited by AABB and other global certifications.
